Seminars and Presentations
September, 1986: ‘Phosphatidylcholine Turnover in a Neural Tumor Cell Line’, Annual Harvard Medical School M.D., Ph.D. Program Retreat, Marine Biological Laboratories, Woods Hole, MA.
April, 1987: ‘Safety Issues Relating to Aspartame Consumption’, presented at the Case Report on Phenylalanine Production (for the Synthesis of Aspartame), to Industry and University Representatives, Dept. Applied Biological Sciences, Massachusetts Institute of Technology, Cambridge, MA.
May, 1987: ‘Therapeutic Alternatives to Tissue Plasminogen Activator’, Summary Perspective on Tissue Plasminogen Activator, presented at the Case Report on Tissue Plasminogen Activator, to Industry and University Representatives, Dept. Applied Biological Sciences, Massachusetts Institute of Technology, Cambridge, MA.
August, 1987: ‘Industrial Scale Production of Human Serum Albumin through the Development of a Transgenic Chicken’, presented with Prof. W.G. Thilly to Campbell Soup Co., sponsored by the MIT Industrial Liaison Program, Cambridge, MA.
November, 1987: ‘Towards a Tissue Culture Model for Huntington’s Disease’, Neurology Research Seminar Series, Dept. Neurology, Mass. General Hospital, Boston, MA.
March, 1988: ‘Intrastriatal Quinolinic Acid Levels following Tryptophan Administration: Pathogenetic Link to Huntington’s Disease?’, Neurology Research Seminar Series, Massachusetts General Hospital, Boston, MA.
June, 1988: ‘Drug Delivery Systems for Neurological Disorders’, University/Incubator Spin Off Companies Conference, Westin Hotel, Boston, MA, hosted by the MIT Office of Technology Licensing.
October, 1988: ‘Characterization and Mechanism of Glutamate Neurotoxicity in Primary Striatal Cultures’, Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA.
October, 1989: ‘Excitotoxic Mechanisms in Huntington’s Disease and the Kynurenine Pathway’, Massachusetts Institutes of Technology, Division of Health Sciences and Technology, Cambridge, MA.
April, 1991: ‘Brain Tissue Transplantation’, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
November, 1991: ‘Excitotoxic Mechanisms in Huntington’s Disease’ Ph.D. Thesis Defense, Massachusetts Institute of Technology, Cambridge, MA.
November, 1992: ‘Novel Therapeutic Approaches to Parkinson’s Disease: Drug and Gene Delivery Systems’, Grand Rounds, Departments of Neurology and Neurosurgery, University of Pennsylvania, Philadelphia, PA.
November, 1992: ‘Spinal Epidural Abscesses’, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
March, 1993: ‘Neurosurgical Approaches to Parkinson’s Disease: Past, Present and Future’, Surgical Grand Rounds, Graduate Hospital, Philadelphia, PA.
November, 1993: ‘Pharmacology of the Kynurenenine Pathway: Endogenous Neuroprotection’, Wyeth Ayerst Laboratories, Radnor, PA.